Therefore, biological agents that target TNF‐α can be used to treat various TNF‐α–related diseases such as rheumatoid arthritis (RA), septic shock, ankylosing spondylitis (AS), psoriasis, and other autoimmune diseases and to suppress the immunological rejection mechanisms underlying organ transplantation.5 This evidence concerns the gene TNF and ankylosing spondylitis.